Clinical Context
A 62-year-old female undergoing outpatient chemotherapy for metastatic breast cancer presents to the oncology infusion suite with a history of severe nausea and vomiting related to her cisplatin-based regimen. The oncology nurse verifies orders and prepares an intravenous antiemetic. The medication administered is ondansetron hydrochloride by IV push or infusion, dosed per milligram using HCPCS Level II code J2405 (injection, ondansetron hydrochloride, per 1 mg). The nurse documents indication, dose, route, lot number, and site of administration in the electronic health record and records the associated ICD-10 diagnosis for chemotherapy-induced nausea and vomiting.
The clinical workflow includes medication reconciliation and allergy check, confirmation of IV access, verification of the provider order and patient identity, preparation of ondansetron per institutional policy, administration by a licensed clinician, monitoring for immediate adverse effects (e.g., QT prolongation symptoms, headache, constipation), and documentation of response to therapy. Billing staff link the administered milligrams to J2405 units and append an appropriate modifier if necessary (for example, a modifier indicating distinct procedural service or medically necessary service level).